Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
39.6M
-
Shares change
-
+85.6K
-
Total reported value, excl. options
-
$590M
-
Value change
-
-$2.51M
-
Number of buys
-
52
-
Number of sells
-
-51
-
Price
-
$14.88
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2021
129 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q4 2021.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.6M shares
of 84.7M outstanding shares and own 46.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.7M shares), FRANKLIN RESOURCES INC (3.27M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.71M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.44M shares), First Light Asset Management, LLC (2.25M shares), VANGUARD GROUP INC (2.12M shares), BAILLIE GIFFORD & CO (1.86M shares), SV Health Investors, LLC (1.82M shares), FRAZIER MANAGEMENT LLC (1.78M shares), and Samsara BioCapital, LLC (1.68M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.